Video

Dr. Hurvitz on Using ADCs in HER2+ Breast Cancer

Sara A. Hurvitz, MD, associate professor of medicine and medical oncologist, University of California Los Angeles, discusses the use of antibody-drug conjugates in HER2-positive breast cancer.

Sara A. Hurvitz, MD, associate professor of medicine and medical oncologist, University of California Los Angeles, discusses the use of antibody-drug conjugates (ADCs) in HER2-positive breast cancer.

ADCs combine a very specifically targeted antibody that targets the tumor cells more than the normal cells with a cytotoxic payload, which is a very potent type of chemotherapy, explains Hurvitz. This allows the chemotherapy to be directed to the antigen-overexpressing tumor cell. By targeting chemotherapy directly to the antigen overexpressing tumor cells, the toxicity is limited in normal cells.

While patients get a very toxic type of chemotherapy with the ADCs, the chemotherapy targets the HER2 antigen; therefore, patients do not have hair loss and avoid other typical adverse events caused by cytotoxic chemotherapy.

<<< View more from 2019 San Antonio Breast Cancer Symposium

Related Videos
Benjamin P. Levy, MD, with Kristie Kahl and Andrew Svonavec
Dana Zakalik, MD
Alberto Montero, MD, MBA, CPHQ
Jairam Krishnamurthy, MD, FACP
Deena Mary Atieh Graham, MD
Sheldon M. Feldman, MD
Sheldon M. Feldman, MD
In this episode of OncChats: Empowering Community Cancer Care, Dr. Rai emphasizes the importance of community outreach and support for patients with cancer, highlighting the need for holistic care that addresses both physiological and psychological aspects of treatment while reinforcing the value of strong relationships between primary care physicians and specialists.
In this episode of OncChats: Empowering Community Cancer Care, Dr. Woodworth sheds light on the “Road to Recovery” survivorship program at Henry Mayo, which supports cancer survivors by providing them with fitness, education, and mental health resources, and underscores the importance of mentorship programs for community providers to ensure equitable cancer care.
In this episode of OncChats: Empowering Community Cancer Care, Drs Woodworth and Rai, discuss their collaborative approach to cancer screening, emphasizing the importance of community efforts and individual assessments in integrating genetic testing and screenings into routine practice.